Universitätsklinikum Augsburg

Quality assurance and improvement in oncology using guideline-derived quality indicators - results of gynaecological cancer centres certified by the German cancer society (DKG) (2022) Griesshammer E, Wesselmann S, Beckmann M, Dannecker C, Wagner U, Sibert NT, Armbrust R, Sehouli J Journal article Molecular Assessment of Staphylococcus Aureus Strains in STAT3 Hyper-IgE Syndrome Patients (2022) Schwierzeck V, Effner R, Abel F, Reiger M, Notheis G, Held J, Simon V, et al. Journal article Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis (2022) Rodriguez-Arboli E, Labopin M, Eder M, Brecht A, Blau IW, Huynh A, Forcade E, et al. Journal article RHABDOID TUMOR PREDISPOSITION SYNDROME (RTPS) - FINDING EVIDENCE BY SYSTEMATIC ANALYSES (2022) Nemes K, Bens S, Johann PD, Steinbuegl M, Gruhle M, Kachanov D, Teleshova M, et al. Conference contribution INFANTS AND NEWBORNS WITH ATYPICAL TERATOID/RHABDOID TUMORS (ATRT) AND EXTRACRANIAL MALIGNANT RHABDOID TUMORS: A UNIQUE AND CHALLENGING POPULATION (2022) Nemes K, Johann PD, Steinbuegl M, Gruhle M, Bens S, Kachanov D, Teleshova M, et al. Conference contribution Update Breast Cancer 2022 Part 2 - Advanced Stage Breast Cancer (2022) Müller V, Welslau M, Lüftner D, Schütz F, Stickeler E, Fasching P, Janni W, et al. Journal article, Review article Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population (2022) Nemes K, Johann PD, Steinbügl M, Gruhle M, Bens S, Kachanov D, Teleshova M, et al. Journal article Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis (2022) Voskens C, Stoica D, Rosenberg M, Vitali F, Zundler S, Ganslmayer M, Knott H, et al. Journal article Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group (2022) Bakhuizen JJ, Hanson H, Van De Tuin K, Lalloo F, Tischkowitz M, Wadt K, Doergeloh BB, et al. Conference contribution Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany (2022) Mohr P, Scherrer E, Assaf C, Bender M, Berking C, Chandwani S, Eigentler T, et al. Journal article